Finance

Lists
ACA:NYSE
Arcosa Inc
$146.59
+0.06%
(+0.090) 1D
Oct 2, 12:21:04 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACA...
Open
$146.79
High
$147.00
Low
$146.50
Mkt. cap
7.20B
Avg. vol.
667.06K
Volume
103.79K
Dividend
0.14%
Quarterly dividend
$0.05
Ex-dividend date
Oct 15, 2026
P/E ratio
14.69
52-wk high
$147.00
52-wk low
$89.03
EPS
$9.98
Beta
1.08
Shares outstanding
49.11M
No. of employees
6K
Open
$146.79
High
$147.00
Low
$146.50
Mkt. cap
7.20B
Avg. vol.
667.06K
Volume
103.79K
Dividend
0.14%
Quarterly dividend
$0.05
Ex-dividend date
Oct 15, 2026
P/E ratio
14.69
52-wk high
$147.00
52-wk low
$89.03
EPS
$9.98
Beta
1.08
Shares outstanding
49.11M
No. of employees
6K
News stories
From web sources and news partners
About Arcosa Inc
CEO-
Employees6.39K
FoundedNov 1, 2018
HeadquartersDallas, Texas, United States
SectorConstruction
Websitearcosa.com
Analyst ratings
Based on 1 analyst giving stock ratings to ACA in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ACA in the last 3 months
Highest
Current $146.59
$150.00 (+2.33%)
Average
$150.00 (+2.33%)
Lowest
$150.00 (+2.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Trey Grooms
Stephens
Hold
Downgraded
$150.00
+2.3%
08/06/2026
Brent Thielman
Oppenheimer
Hold
Downgraded
$150.00
+2.3%
06/26/2026
Min Cho
Texas Capital Securities
Hold
Downgraded
$150.00
+2.3%
06/22/2026
Alex Rygiel
Texas Capital Securities
Hold
Downgraded
$150.00
+2.3%
06/23/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
$150.00
+2.3%
05/28/2026
Adam Seiden
Barclays
Buy
Maintained
$140.00
-4.5%
05/04/2026
Unknown Analyst
Stephens
Buy
Maintained
$135.00
-7.9%
04/02/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$1.13 / $1.18
-4.52%miss
Revenue / Est. (USD)
658.70M / 686.10M
-3.99%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
797.80M
716.70M
571.70M
658.70M
Cost of goods sold
605.90M
552.90M
450.80M
503.00M
Cost of revenue
605.90M
552.90M
450.80M
503.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
82.10M
79.60M
73.90M
74.60M
Operating expense
79.50M
117.40M
71.90M
74.60M
Total operating expenses
685.40M
670.30M
522.70M
577.60M
Operating income
112.40M
46.40M
49.00M
81.10M
Other non operating income
-
1.60M
-100.00K
-2.60M
EBT including unusual items
87.10M
55.20M
24.60M
62.30M
EBT excluding unusual items
87.20M
22.60M
26.50M
59.10M
Income tax expense
14.10M
3.10M
1.30M
11.40M
Effective tax rate
16.19%
5.62%
5.28%
18.30%
Other operating expenses
-2.60M
37.80M
-2.00M
-
Net income
73.00M
52.10M
37.80M
328.50M
Net profit margin
9.15%
7.27%
6.61%
49.87%
Earnings per share
1.56
1.15
0.81
1.13
Interest and investment income
1.80M
1.70M
1.60M
3.70M
Interest expense
-27.10M
-24.90M
-24.00M
-23.10M
Net interest expenses
-25.30M
-23.20M
-22.40M
-19.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
168.60M
103.50M
102.50M
139.10M
Gain or loss from assets sale
-4.60M
7.00M
-2.00M
-17.70M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps